Concepedia

Catherine Stedman

CS

Statistics

Publications

51

Citations

6K

H-Index

34

Active since

2002

Affiliations

University of Otago(Current)

Christchurch Hospital

Auckland City Hospital

Gilead Sciences (United States)

Auckland Institute of Studies

Catherine Stedman is an author at University of Otago specializing in antiviral therapy, viral hepatitis, and virology.

ORCID

Publications per year

2002–2025

51

Publications

51

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

Graham R. Foster, Nezam H. Afdhal, Stuart K. Roberts et al. · New England Journal of Medicine · 2015 · 850 citations · Full text

, , +17

Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C

Edward Gane, Catherine Stedman, Robert H. Hyland et al. · New England Journal of Medicine · 2013 · 759 citations · Full text

, , +14

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

Susanna Naggie, Curtis Cooper, Michael S. Saag et al. · New England Journal of Medicine · 2015 · 467 citations · Full text

, , +17

Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

Stefan Zeuzem, Graham R. Foster, Stanley Wang et al. · New England Journal of Medicine · 2018 · 437 citations · Full text

, , +17

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 421 citations · Full text

, , +12

1–5 of 51